Pierre F.
- Country
- France
- Department
- Hématologie
Research Overview
- Evaluation of Tumor Lysis Syndrome Risk in Chronic Lymphocytic Leukemia Patients Treated with Venetoclax, Obinutuzumab, or Acalabrutinib Combinations
- Phase III Randomized Double-Blind Trial of Polatuzumab Vedotin, Rituximab, and CHP vs. Rituximab and CHOP in Untreated Diffuse Large B-Cell Lymphoma
- Study PACIFIC: Fixed duration treatment with combined pirtobrutinib and short course immuno-chemotherapy in fit patients with previously untreated symptomatic chronic lymphocytic leukemia (CLL). A phase II FILO trial
Data & Insights
Has run more than one trial at 20 of 99 partner sites.
Specializations
Hematological Disorders
This investigator specializes in treating primary immune thrombocytopenia (ITP), focusing on innovative therapeutic approaches combining corticosteroid treatments with novel agents. Their research explores advanced treatment strategies for patients with this autoimmune blood disorder.
- First-line treatment optimization
- Corticosteroid therapy enhancement
- Novel therapeutic combinations
Their work particularly centers on improving treatment outcomes for newly diagnosed ITP patients.
Oncology - Blood Cancers
The investigator demonstrates expertise in treating Chronic Lymphocytic Leukemia (CLL), with particular attention to managing treatment-related complications. Their research involves evaluating innovative combination therapies including targeted agents.
- Treatment safety assessment
- Novel drug combinations
- Tumor burden management
Their focus includes optimizing treatment protocols for previously untreated CLL patients.
Treatment Risk Management
The investigator specializes in assessing and managing Tumor Lysis Syndrome risks in blood cancer treatments. Their expertise extends to evaluating complex drug combinations and their safety profiles in various patient populations.
- Risk assessment protocols
- Safety monitoring strategies
- Treatment adaptation methods
Their work emphasizes patient safety during intensive therapeutic interventions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.